Non-PVC IV Bags Market Opportunities and Strategies to 2034

This report describes and explains the non-PVC IV bags market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global non-PVC IV bags market reached a value of nearly $2.06 billion in 2024, having grown at a compound annual growth rate (CAGR) of 10.25% since 2019. The market is expected to grow from $2.06 billion in 2024 to $3.41 billion in 2029 at a rate of 10.58%. The market is then expected to grow at a CAGR of 10.79% from 2029 and reach $5.69 billion in 2034.

Growth in the historic period resulted from the increase in healthcare expenditure, rising demand from biopharmaceutical and biologics sectors, growth in home healthcare services and shift toward single-use medical devices. Factors that negatively affected growth in the historic period were stringent regulatory standards and recycling and waste management issues.

Going forward, the growing prevalence of chronic diseases, increasing aging population, increase in chemotherapy and rising demand for eco-friendly and recyclable medical packaging materials will drive the growth. Factor that could hinder the growth of the non-PVC IV bags market in the future include higher cost of non-PVC IV bags, limited manufacturing infrastructure and impact of trade war and tariff.

North America was the largest region in the non-PVC IV bags market, accounting for 43.36% or $894.53 million of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the non-PVC IV bags market will be Asia Pacific and Africa where growth will be at CAGRs of 12.60% and 11.36% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 10.68% and 10.35% respectively.

The global non-PVC IV bags market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 25.14% of the total market in 2024. B. Braun Melsungen AG. was the largest competitor with a 6.24% share of the market, followed by Baxter International. with 5.97%, JW Life Science with 4.97%, Fresenius SE with 4.44%, ICU Medical Inc. with 1.58%, Renolit Group with 0.67%, Polycine GmbH with 0.33%, Kraton Corporation with 0.32%, Angiplast Pvt. Ltd. with 0.32% and Technoflex SA with 0.31%.

The non-PVC IV bags market is segmented by product into single chamber and multi chamber. The single chamber market was the largest segment of the non-PVC IV bags market segmented by product, accounting for 64.31% or $1.32 billion of the total in 2024. Going forward, the multi chamber segment is expected to be the fastest growing segment in the non-PVC IV bags market segmented by product, at a CAGR of 13.33% during 2024-2029.

The non-PVC IV bags market is segmented by material into ethylene vinyl acetate, polypropylene, copolyester ether and other materials. The polypropylene market was the largest segment of the non-PVC IV bags market segmented by material, accounting for 40.85% or $842.89 million of the total in 2024. Going forward, the copolyester ether segment is expected to be the fastest growing segment in the non-PVC IV bags market segmented by material, at a CAGR of 14.56% during 2024-2029.

The non-PVC IV bags market is segmented by content into frozen mixture and liquid mixture. The liquid mixture market was the largest segment of the non-PVC IV bags market segmented by content, accounting for 78.65% or $1.62 billion of the total in 2024. Going forward, the frozen mixture segment is expected to be the fastest growing segment in the non-PVC IV bags market segmented by content, at a CAGR of 13.78% during 2024-2029.

The non-PVC IV bags market is segmented by application into chemotherapy, targeted drug delivery, glucose injection, sodium chloride solution, electrolyte injection, nutrient injection and other applications. The chemotherapy market was the largest segment of the non-PVC IV bags market segmented by application, accounting for 32.33% or $667.04 million of the total in 2024. Going forward, the targeted drug delivery segment is expected to be the fastest growing segment in the non-PVC IV bags market segmented by application, at a CAGR of 14.80% during 2024-2029.

The non-PVC IV bags market is segmented by end user into hospitals, clinics, emergency service centers, ambulatory surgical centers and other end users. The hospitals market was the largest segment of the non-PVC IV bags market segmented by end user, accounting for 62.63% or $1.29 billion of the total in 2024. Going forward, the ambulatory surgical centers segment is expected to be the fastest growing segment in the non-PVC IV bags market segmented by end user, at a CAGR of 16.37% during 2024-2029.

The top opportunities in the non-PVC IV bags markets segmented by product will arise in the single chamber segment, which will gain $707.54 million of global annual sales by 2029. The top opportunities in the non-PVC IV bags markets segmented by material will arise in the polypropylene segment, which will gain $601.62 million of global annual sales by 2029. The top opportunities in the non-PVC IV bags markets segmented by content will arise in the liquid mixture segment, which will gain $948.49 million of global annual sales by 2029. The top opportunities in the non-PVC IV bags markets segmented by application will arise in the chemotherapy segment, which will gain $620.6 million of global annual sales by 2029. The top opportunities in the non-PVC IV bags markets segmented by end user will arise in the hospitals segment, which will gain $808.38 million of global annual sales by 2029. The non-PVC IV bags market size will gain the most in the USA at $448.57 million.

Market-trend-based strategies for the non-PVC IV bags market include strategic collaboration and partnerships to accelerate product development, expand global reach and developing innovative products such as multilayer polyolefin IV bags to improve drug stability.

Player-adopted strategies in the non-PVC IV bags market include focus on enhancing its business operations through new launches and focus on improving its portfolio through strategic partnerships.

To take advantage of the opportunities, the analyst recommends the non-PVC IV bags market companies to focus on product innovation to strengthen market position, focus on multi-chamber non-PVC IV bags to drive growth, focus on copolyester ether to capture high-growth opportunities, focus on frozen mixtures to maximize growth potential, expand in emerging markets, focus on strategic partnerships to drive innovation and regulatory compliance, focus on value-based pricing to reflect product benefits and market position, focus on clinical evidence to drive adoption through targeted promotion, focus on strategic stakeholder engagement to strengthen brand credibility, focus on targeted drug delivery to capture high-growth therapeutic demand and focus on ambulatory surgical centers to capture rapid outpatient growth.